Approximately 12,504 bottles of Telmisartan and Amlodipine (80 mg/5 mg) tablets are being recalled. This medication, used to treat high blood pressure, failed quality testing during an 18-month stability study because it did not meet specifications for impurities and degradation. Consumers should contact their healthcare provider or pharmacist to discuss alternative treatments and return any unused medication to the pharmacy for a refund.
The tablets may contain higher levels of impurities or degradation products than allowed, which can potentially reduce the medication's effectiveness or expose patients to unintended chemical compounds over time.
Refund for unused prescription medication.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.